Navigation Links
John Daly, Previous Merck Exec., Starts CTW Consulting Firm
Date:12/2/2013

NEW YORK, Dec. 2, 2013 /PRNewswire-iReach/ -- Former Merck executive, John Daly, recently founded CTW with two primary missions.

(Photo: http://photos.prnewswire.com/prnh/20131202/MN25895)

The first is to offer pharmaceutical industry consulting services to corporations such as IMS Health. Providing strategy for next-generation commercialization solutions focused on integrated and accountable care emerging stakeholders and next-generation sales excellence solutions for the new pharma environment.

In addition, CTW's front-line leadership and coaching mission is to ensure their clients identify and cultivate engaging leadership. Through customer centric coaching, CTW clients empower culture, fuel innovation and the full realization of their vision.

"A great business model, people, commercial opportunity and a defined vision is not enough. Investing in and putting your people first means having purposeful, strategic and effective front-line leaders." said Daly. CTW's Customer Centric Coaching model ingrains four core coaching principles that enable sales leaders to identify, leverage and build upon what motivates individual sales professionals.

Daly's previous employment as director of commercial operations and regional sales director at Schering Plough / Merck has allowed him to fuel hundreds of millions in sales by directing multiple regions and teams in brand sales to primary care, multispecialty, integrated physician groups, and managed care organizations. Daly has also strengthened and led innovative healthcare partnerships, solutions and quality outcome-focused strategies.

To learn more about John Daly and CTW visit http://john-daly-merck.com/

About John Daly

With two decades of experience in the pharmaceutical industry, John Daly has served as a sales leader and director of commercial operations since 2004 with Bayer Healthcare, Schering Plough Corporation and Merck & Co., Inc. based in North Wales, Pennsylvania. He has led the commercial operations of several regions in a number of therapeutic areas including respiratory allergy and asthma, diabetes, neurology and cardiovascular disease. His success has included developing current leaders, brand team partnerships and field leadership of multiple product launches and excellent integration and change leadership. Daly's consistent strong performance as a regional sales director has earned him a number of sales awards and corporate recognitions spanning cross-functional programs and special initiatives.

Media Contact: Deanna Dunsmuir, X Factor Selling Systems, 9736008321, deanna@thesalesexpertusa.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE CTW consulting
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Gen-Probe Withdraws from Previously Announced Investor Presentations
2. Genesis Biopharma Announces Termination of Previously Announced Proposed Public Offering
3. Johnson & Johnson Expects to Incur Special Charge in Second Quarter for Previously Disclosed Legal Matters
4. Statement from Mary Vogt, President of Home Access Health Corporation, manufacturer of the Home Access HIV-1 test system, the only over-the-counter HIV test previously approved by the FDA for at-home use.
5. PDI, Inc. Announces Client FDA Product Approval Related to Previously Disclosed Contract
6. Bausch + Lomb Announces Extension of Early Tender Date for Its Previously Announced Tender Offer for Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3, U07190AA6 and 071707AP8)
7. Bausch + Lomb Announces Final Results for Its Previously Announced Tender Offer for Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3, U07190AA6 and 071707AP8)
8. Medical Alarm Provides Investor Update -- Company Surpassing Previous Record Order Levels as Consumer Interest Accelerates
9. Assisted Reproduction: New Technology Identifies Previously Unknown Predictors of Embryo Viability
10. Volcano Announces Previous St. Jude Medical Products Infringe Volcano Patent and Jury Verdicts in Patent Trials with St. Jude Medical
11. Hemodialysis Patient Share for Sanofis Ferrlecit Increased Significantly in the First Quarter of 2013 Compared to the Previous Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... Feb. 22, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE ... the quarter and full fiscal year ended December 31, 2016. ... ... Company,s audited financial statements and management discussion and analysis for ... been filed on SEDAR and are available at www.sedar.com ...
(Date:2/22/2017)... Feb. 22, 2017 Merrimack Pharmaceuticals, Inc. (Nasdaq: ... its Fourth Quarter 2016 investor conference call and webcast at ... The call will cover an update on Merrimack,s recent ... full year 2016 financial results. A press release detailing the ... the morning of Wednesday, March 1. Investors and the general ...
(Date:2/22/2017)... NEW YORK , Feb. 22, 2017 ... non-small cell lung cancer partnering deals and agreements entered ... the full report: http://www.reportlinker.com/p03605668-summary/view-report.html Description The ... since 2010 report provides understanding and access to partnering ... healthcare companies. - Trends in partnering deals ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... , ... The Waismann Method® is providing a faster, safer, and ... victim to America’s opioid epidemic. Now, opiate dependent individuals can be treated in a ... the shame, stigma, and harmful labeling believed to prevent many of these ...
(Date:2/22/2017)... ... February 22, 2017 , ... VitreosHealth ... each Medicare Advantage member’s risk, identify any gaps-in-coding, as well as gaps-in-care ... transform the HCC Risk Adjustment process from a typical fragmented process to ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... newest advanced absorption cannabidiol (CBD) serum, “NANOCALM 300” Microemulsified Hemp Extract. This ... instant absorption from the mouth into the bloodstream. Far outpacing the ...
(Date:2/22/2017)... ... February 22, 2017 , ... Becker’s Spine Review, the ... featuring Michigan neurosurgeon Jay Jagannathan, M.D., as a “Spine Surgeon to Know.” ... neurosurgeons in Michigan performing minimally invasive back surgery that often results in less ...
(Date:2/22/2017)... ... February 22, 2017 , ... The SeniorCare Investor will host an important webinar— ... 23, 2017, at 1:00 PM ET. A recording of the webinar will also be ... Series. , If you want to find out what really happened in the seniors ...
Breaking Medicine News(10 mins):